Press Releases about Paxmedica Inc
Study Links Microbiome Composition to Autism Spectrum Disorder
February 16, 2024
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
PaxMedica Releases Fireside Chat Video with CEO Howard Weisman
December 06, 2023
Via ACCESSWIRE
Israeli Study Offers Hope to Sleeping Sickness Patients
December 26, 2023
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) CEO Featured in Just-Released Fireside Chat Video
December 06, 2023
Exposures
Product Safety
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
PaxMedica Announces Closing of $7.0 Million Public Offering
November 22, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
PaxMedica Announces Pricing of $7.0 Million Public Offering
November 20, 2023
Via ACCESSWIRE
Study Examines Role of African Sleeping Sickness in Body Wasting
November 17, 2023
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Releases Q3 2023 Financial Report, Corporate Update
November 16, 2023
Exposures
Product Safety
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
PaxMedica, Inc. Announces Third Quarter 2023 Financial Results and Business Update
November 15, 2023
Via ACCESSWIRE
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) CMO Featured in Latest Bell2Bell Podcast Release
November 09, 2023
Exposures
Product Safety
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.